Method of treating cancer with a pharmaceutical formulation comprising a HER2 antibody

• 收藏
• 分享

专利权人:

Genentech; Inc.

发明人:

James Andya,Shiang C. Gwee,Jun Liu,Ye Shen

申请号：

US13660114

公开号：

US09017671B2

申请日:

2012.10.25

申请国别(地区):

US

年份:

2015

代理人:

摘要：

The present application describes antibody formulations, including monoclonal antibodies formulated in histidine-acetate buffer, as well as a formulation comprising an antibody that binds to domain II of HER2 (for example, Pertuzumab), and a formulation comprising an antibody that binds to DR5 (for example, Apomab).

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/